|
Market Closed -
Nasdaq
23:00:00 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 6.835 USD | -14.35% |
|
+62.35% | -76.32% |
| 08-14 | Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes | RE |
| 08-14 | Capricor Therapeutics Shares Surge 98% as FDA Agrees to Review Deramiocel Application Amendment | MT |
| Market Cap | 397M 340M 317M 291M 547M 38.02B 558M 3.77B 1.47B 19.06B 1.49B 1.46B 63.09B | P/E 2026 * |
-3.07x | P/E 2027 * | -4.13x |
|---|---|---|---|---|---|
| Enterprise Value | 397M 340M 317M 291M 547M 38.02B 558M 3.77B 1.47B 19.06B 1.49B 1.46B 63.09B | EV / Sales 2026 * |
25.1x | EV / Sales 2027 * | 9.19x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -14.35% | ||
| 1 week | +62.35% | ||
| Current month | +77.53% | ||
| 1 month | -64.95% | ||
| 3 months | -76.44% | ||
| 6 months | -76.03% | ||
| Current year | -76.32% |
| 1 week | 6.59 |  | 8.29 |
| 1 month | 2.96 | | 20.54 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/2/26 A | Fiscal year | Director | 22,587 | 0.0393% | ||
| 1/5/26 A | Free | Director | 15,500 | 0.0285% | ||
| 1/5/26 A | Free | Chief Financial Officer | 52,500 | 0.0965% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.35% | +62.35% | -4.67% | -1.09% | 397M | |
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | |
| -0.34% | +20.82% | +53.16% | +93.42% | 64.66B | |
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | |
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| -0.47% | +5.13% | +35.39% | -14.59% | 19.98B | |
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | |
| Average | -1.84% | +11.80% | +52.58% | +179.97% | 28.75B | |
| Weighted average by Cap. | +0.02% | +8.28% | +58.89% | +160.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.82M 13.55M 12.64M 11.6M 21.79M 1.51B 22.22M 150M 58.45M 759M 59.41M 58.12M 2.51B | 43.24M 37.02M 34.54M 31.69M 59.55M 4.14B 60.73M 410M 160M 2.07B 162M 159M 6.86B |
| Net income | -129M -111M -103M -94.64M -178M -12.35B -181M -1.22B -477M -6.19B -485M -474M -20.5B | -99.36M -85.08M -79.38M -72.84M -137M -9.51B -140M -942M -367M -4.76B -373M -365M -15.77B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | $6.835 | -14.35% | 8,108,942 |
| 19/08/26 | $7.980 | +12.71% | 8,565,517 |
| 18/08/26 | $7.080 | -4.97% | 8,538,983 |
| 17/08/26 | $7.450 | +12.03% | 19,218,779 |
| 14/08/26 | $6.650 | +57.96% | 66,333,884 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
